Effects of cell number on teratoma formation by human embryonic stem cells.

Effects of cell number on teratoma formation by human embryonic stem cells.
复制标题

DOI:
10.4161/cc.8.16.9353
复制
发表时间:
2009-08-15
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
通讯作者:
Wu JC
Wu JC
中科院分区:
其他
文献类型:
--
作者:
Lee AS;Tang C;Cao F;Xie X;van der Bogt K;Hwang A;Connolly AJ;Robbins RC;Wu JC

文献摘要

参考文献

被引文献

相似文献

Teratoma formation is a critical obstacle to safe clinical translation of human embryonic stem (ES) cell-based therapies in the future. As current methods of isolation are unable to yield 100% pure population of differentiated cells from a pluripotent donor source, potential development of these tumors is a significant concern. Here we used non-invasive reporter gene imaging to investigate the relationship between human ES cell number and teratoma formation in a xenogenic model of ES cell transplantation. Human ES cells (H9 line) were stably transduced with a double fusion (DF) reporter construct containing firefly luciferase and enhanced green fluorescent protein (Fluc-eGFP) driven by a human ubiquitin promoter. Immunodeficient mice received intramyocardial (n = 35) or skeletal muscle (n = 35) injection of 1 × 102, 1 × 103, 1 × 104, 1 × 105 or 1 × 106 DF positive ES cells suspended in saline for myocardium and Matrigel for skeletal muscle. Cell survival and proliferation were monitored via bioluminescence imaging (BLI) for an 8 week period following transplantation. Mice negative for Fluc signal after 8 weeks were followed out to day 365 to confirm tumor absence. Significantly, in this study, a minimum of 1 × 105 ES cells in the myocardium and 1 × 104 cells in the skeletal muscle was observed to be requisite for teratoma development, suggesting that human ES cell number may be a critical factor in teratoma formation. Engraftment and tumor occurrence were also observed to be highly dependent on ES cell number. We anticipate these results should yield useful insights to the safe and reliable application of human ES cell derivatives in the clinic.
DOI: 10.1161/circulationaha.105.588954
发表时间: 2006-02-21
期刊: CIRCULATION
影响因子: 37.8
作者:
Cao, F;Lin, S;Wu, JC
通讯作者: Wu, JC
DOI: 10.1046/j.1471-4159.2003.02243.x
发表时间: 2004-03-01
影响因子: 4.7
作者:
Harkany, T;Andäng, M;Ernfors, P
通讯作者: Ernfors, P
DOI: 10.1096/fj.06-6769com
发表时间: 2007-05-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者:
Nussbaum, Jeannette;Minami, Elina;Murry, Charles E.
通讯作者: Murry, Charles E.
DOI: 10.1126/science.282.5391.1145
发表时间: 1998-11-06
期刊: SCIENCE
影响因子: 56.9
作者:
Thomson, JA;Itskovitz-Eldor, J;Jones, JM
通讯作者: Jones, JM
DOI: 10.1002/pmic.200600150
发表时间: 2006-12-01
期刊: PROTEOMICS
影响因子: 3.4
作者:
Wu, Joseph C.;Cao, Feng;Wang, Evelyn W.
通讯作者: Wang, Evelyn W.